β³ Fetching live dividend data...
Home βΊ Calculator βΊ ELUT Dividend Calculator 2026
Elutia Inc Β· NASDAQ
Price: $0.96 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ELUT β $819653125193456.75M in 10 years Β· $68,272,317,775,001,166,000.00/month
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Womenβs Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ELUT position with:
Real after-tax yield depends on where you live and how you hold ELUT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 207.64% | 204.84% | $20,764 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 176.49% | 173.69% | $17,649 / yr |
| πΊπΈ US Taxable (20%) | 20% | 166.11% | 163.31% | $16,611 / yr |
| π¬π§ UK ISA | 0% | 207.64% | 204.84% | $20,764 / yr |
| π¬π§ UK Taxable | 8.75% | 189.47% | 186.67% | $18,947 / yr |
| π¨π¦ TFSA | 0% | 207.64% | 204.84% | $20,764 / yr |
| π¨π¦ CA Taxable | 25% | 155.73% | 152.93% | $15,573 / yr |
| π¦πΊ Super (pension) | 15% | 176.49% | 173.69% | $17,649 / yr |
| π¦πΊ AU Taxable | 30% | 145.35% | 142.55% | $14,535 / yr |
| π©πͺ DE Taxable | 26.375% | 152.87% | 150.07% | $15,287 / yr |
| π«π· FR Taxable | 30% | 145.35% | 142.55% | $14,535 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
ELUT pays quarterly β 4 times per year. Next ex-div: TBD.
How ELUT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ELUT sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-06-21 | 22,473 | β | β | ||
| F-InKind | 2026-06-21 | 8,064 | $1.06 | $8.5K | ||
| M-Exempt | 2026-06-21 | 22,473 | β | β | ||
| A-Award | 2026-06-11 | 159,590 | $0.96 | $153.2K | ||
| A-Award | 2026-06-11 | 106,393 | $0.96 | $102.1K | ||
| A-Award | 2026-06-11 | 106,393 | $0.96 | $102.1K | ||
| A-Award | 2026-06-11 | 106,393 | $0.96 | $102.1K | ||
| M-Exempt | 2026-06-10 | 12,500 | β | β | ||
| F-InKind | 2026-06-10 | 4,269 | $1.04 | $4.4K | ||
| M-Exempt | 2026-06-10 | 12,500 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ELUT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Elutia Inc (ELUT) is currently trading at $0.96, 94% below its 52-week high. The current dividend yield is 207.64% based on an annual payout of $2.00 per share.
Elutia Inc (ELUT) is a healthcare stock currently trading at $0.96 with a dividend yield of 207.64%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β